| Literature DB >> 34548225 |
Ying Wang1, Xin-Yi Zhou1, Xiang-Yun Lu2, Ke-Da Chen1, Hang-Ping Yao3.
Abstract
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide with high mortality. The incidence of HCC is increasing in China. Abnormal activation of glucose-6-phosphate dehydrogenase (G6PD) exists in all malignant tumors, including HCC, and is closely related to the development of HCC. In addition, the differential expression of non-coding RNAs is closely related to the development of HCC. This systematic review focuses on the relationship between G6PD, HCC, and non-coding RNA, which form the basis for the circRNA/miRNA/G6PD axis in HCC. The circular RNA (circRNA)/microRNA (miRNA)/G6PD axis is involved in development of HCC. We proposed that non-coding RNA molecules of the circRNA/miRNA/G6PD axis may be novel biomarkers for the pathological diagnosis, prognosis, and targeted therapy of HCC.Entities:
Keywords: Glucose-6-phosphate dehydrogenase; Hepatocellular carcinoma; Non-coding RNA
Mesh:
Substances:
Year: 2021 PMID: 34548225 DOI: 10.1016/j.hbpd.2021.08.013
Source DB: PubMed Journal: Hepatobiliary Pancreat Dis Int